Perrigo on Wednesday announced that it has received approval from the Food and Drug Administration for its abbreviated new drug applications to market over-the-counter nicotine polacrilex mini lozenge USP in both 2-mg and 4-mg strengths.
Merck is moving its global headquarters from Whitehouse Station, N.J., to its existing property in Summit, N.J., which currently houses research, manufacturing, animal health and consumer care operations.
"MIA" usually stands for "missing in action," but according to published reports, some consumers south of the U.S. border take it to stand for something that Americans may consider cause for celebration.
In light of a decision by the Ontario government to expand the scope of practice for pharmacists to include administering flu shots, Shoppers Drug Mart has announced that it will offer vaccination clinics in more than 750 stores in Ontario and across Canada.
To help improve flu immunization rates in underserved communities, Walgreens and Access Community Health Network on Tuesday announced a collaboration that will provide 5,000 free flu shot vouchers to Access to help those either without health insurance coverage or those unable to afford the vaccination to get their flu shot.
The U.S. healthcare system's steady migration beyond the exclusive terrain of the physician practices, professional clinics and hospitals — and into the far more accessible and more cost-conscious world of retail pharmacy and health — continues to accelerate. The shift is dramatically expanding access to health services for millions of patients — many of them uninsured or underinsured — and elevating the status of retail clinicians and community pharmacists.
AccuDial Pharmaceutical earlier this year introduced five SKUs across its Children’s AccuDial Acetaminophen Oral Suspension, featuring one of the only weight-based dosing acetaminophen products with an interactive, rotating label.
The Food and Drug Administration has reviewed new data that indicated that budeprion XL (bupropion hydrochloride extended-release tablets) in the 300-mg strength, manufactured by Impax Labs and Teva Pharmaceuticals USA, is not therapeutically equivalent to Wellbutrin XL in the 300-mg strength.
In partnership with international regulatory and law enforcement agencies, the Food and Drug Administration on Thursday announced it had taken action against more than 4,100 Internet pharmacies that illegally sell unapproved drugs to consumers.